KerrodT,
Yes I agree exactly with what you are saying. "Expected Value" is not a valuation, it's a mathematical/statistical expectation. It does highlight how much out of whack the current price is with a return, based on probability of success of the P3 trial, and the likely value if that is successful.
With this sort of company I find it a much easier way to assess the investment. Maybe I didn't make this clear enough.
sc100
"Expected Value", page-7
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.010(3.45%) |
Mkt cap ! $97.94M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 28.0¢ | $40.10K | 140.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 135929 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 20969 | 2 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |